Skip to main content

Advertisement

Log in

Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of Zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The aim of the present study was to prepare and characterize extended-release matrix tablets of zidovudine using hydrophilic Eudragit RLPO and RSPO alone or their combination with hydrophobic ethyl cellulose. Release kinetics was evaluated by using United States Pharmacopeia (USP)-22 type I dissolution apparatus. Scanning electron microscopy was used to visualize the effect of dissolution medium on matrix tablet surface. Furthermore, the in vitro and in vivo newly formulated sustained-release zidovudine tablets were compared with conventional marketed tablet (Zidovir, Cipla Ltd, Mumbai, India). The in-vitro drug release study revealed that either Eudragit preparation was able to sustain the drug release only for 6 hours (94.3%±4.5% release). Combining Eudragit with ethyl cellulose sustained the drug release for 12 hours (88.1%±4.1% release). Fitting the in vitro drug release data to Korsmeyer equation indicated that diffusion along with erosion could be the mechanism of drug release. In vivo investigation in rabbits showed sustained-release pharmacokinetic profile of zidovudine from the matrix tablets formulated using combination of Eudragits and ethylcellulose. In conclusion, the results suggest that the developed sustained-release tablets of zidovudine could perform therapeutically better than conventional dosage forms, leading to improve efficacy and better patient compliance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chien YW, Wearley LL. AIDS and chemotherapy. Drugs Today. 1989;25:19–25.

    CAS  Google Scholar 

  2. Jain S, Umamaheshwari RB, Bhadra D, Jain NK. Ethosomes: a novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent. Ind J Pharm Sci. 2004;66:72–81.

    CAS  Google Scholar 

  3. Jain S, Tiwary AK, Jain NK. Transdermal delivery of an anti-HIV agent using elastic liposomes: mechanism of action., Curr Drug Deliv. In press.

  4. Kieburtz KD, Seidllin M, Lambert JS, Dollis R, Reichman R, Valentine T. Extended follow-up of neuropathy in patients with AIDS and AIDS related complex treated with dideoxyinosine. J Acquir Immuno Defic Syndrom. 1992;5:60–64.

    CAS  Google Scholar 

  5. Klecker RW, Collins JM, Yarchoan R, et al. Plasma and cerebrospinal fluid pharmacokinetics of 3′ azido-3′-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related disease. Clin Pharmacol Ther. 1987;41:407–412.

    Article  PubMed  Google Scholar 

  6. Salsa T, Veiga F, Pina ME. Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Dev Ind Pharm. 1997;23:929–938.

    Article  CAS  Google Scholar 

  7. Sanchez-Lafuente C, Furlanetto S, Fernandez-Arevalo M, et al. Didanosine extended release matrix tablets: optimization of formulation variables using statistical experimental design. Int J Pharm. 2002; 237:107–118.

    Article  CAS  PubMed  Google Scholar 

  8. Alderman DA. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int J Pharm Tech Prod Mfr. 1984;5:1–9.

    CAS  Google Scholar 

  9. Gohel MC, Patel TP, Bariya SH. Studies in preparation and evaluation of pH independent sustained-release matrix tablets of verapamil HCl using directly compressible Eudragits. Pharm Dev Technol. 2003;8:323–333.

    Article  CAS  PubMed  Google Scholar 

  10. Liu J, Zhang F, McGinity JW. Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. Eur J Pharm Biopharm. 2001;52:181–190.

    Article  CAS  PubMed  Google Scholar 

  11. Bettini R, Colombo P, Massimo G, Catellani PL, Vitali T. Swelling and drug release in hydrogel matrices: polymer viscosity and matrix porosity effects. Eur J Pharm Sci. 1994;2:213–219.

    Article  CAS  Google Scholar 

  12. Reddy KR, Mutalik S, Reddy S. Once daily sustained release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS Pharm Sci Tech. 2003;4:E61.

    Article  Google Scholar 

  13. Aulton ME, Wells TI. Pharmaceutics: The Science of Dosage Form Design. London, UK: Churchill Livingstone; 1988.

    Google Scholar 

  14. Government of India Ministry of Health and Family Welfare. The Pharmacopoeia of India. Delhi, India: Controller of Publication; 1996.

    Google Scholar 

  15. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–1149.

    Article  CAS  PubMed  Google Scholar 

  16. Korsmeyer RW, Gurny R, Docler E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.

    Article  CAS  Google Scholar 

  17. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110–111.

    CAS  PubMed  Google Scholar 

  18. Mockel JE, Lippold BC. Zero order release from hydrocolloid matrices. Pharm Res. 1993;10:1066–1070.

    Article  CAS  PubMed  Google Scholar 

  19. Al-Taani BM, Tashtoush BM. Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium. AAPS Pharm Sci Tech. 2003;4:E43.

    Article  Google Scholar 

  20. Pereira AS, Kenney KB, Cohen MS, et al Simultaneous determination of lamivudine and zidovudine concentrations in human seminal plasma using high-performance liquid chromatography and tandem mass spectrometry. J Chromatogr B Biomed Sci Appl. 2000;742:173–183.

    Article  CAS  PubMed  Google Scholar 

  21. Ebube NK, Hikal A, Wyandt CM, Beer DC, Miller LG, Jones AB. Sustained release of acetaminophen from heterogeneous matrix tablets, influence of polymer ratio, polymer loading and coactive on drug release. Pharm Dev Technol. 1997;2:161–170.

    Article  CAS  PubMed  Google Scholar 

  22. Blum MR, Liao SHT, Good SS, De Miranda P. Pharmacokinetic and bioavailability of zidovudine in human. Am. J Med. 1988;85: 189–194.

    Article  CAS  PubMed  Google Scholar 

  23. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex. N Engl J Med. 1987;317:192–197.

    Article  CAS  PubMed  Google Scholar 

  24. Katikaneni PR, Upadrashia SM, Neau SH, Mitra AK. Ethylcellulose matrix controlled-release tablets of a water soluble drug. Int J Pharm. 1995;123:119–125.

    Article  CAS  Google Scholar 

  25. Efentakis M, Koutlis A. Release of furosemide from multiple unit and single unit preparations containing different viscosity grades of sodium alginate. Pharm Dev Technol. 2001;6:91–98.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Subheet Jain.

Additional information

Published: January 3, 2006

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuksal, A., Tiwary, A.K., Jain, N.K. et al. Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of Zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS PharmSciTech 7, 1 (2006). https://doi.org/10.1208/pt070101

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/pt070101

Keywords

Navigation